Literature DB >> 8088616

Metastatic cervical cancer and pelvic inflammatory disease in an AIDS patient.

G S Singh1, J K Aikins, R Deger, S King, J J Mikuta.   

Abstract

The Center for Disease Control (CDC) recently added invasive cervical cancer to its list of surveillance case-defining diseases, and also included cervical dysplasia, carcinoma in situ, and pelvic inflammatory disease (PID) in the classification system. There are several reported cases of cervical cancer in AIDS patients that behaved in an unusually aggressive fashion and responded poorly to therapy. In light of the above-reported cases, it may be expected that cervical cancer may manifest itself in unusual ways in HIV-positive women. A case of aggressive cervical cancer in an AIDS patient with PID is reported. She was admitted with PID and newly diagnosed cervical cancer with recurrent fever spikes despite adequate antibiotic coverage. An aspiration of a presumed psoas abscess revealed metastatic squamous cell carcinoma. These data suggest that not only are HIV-infected women at risk for aggressive and unusual presentations of cervical cancer, but also that coexistent pelvic infection may contribute to development and spread of the disease. Immunosuppression from the virus may increase the incidence and severity of neoplasia. Data suggest that cervical cancer in HIV-infected women is often of advanced stage and responds poorly to treatment. Unique treatment approaches may need to be developed as conventional strategies do not seem to be adequate. More research is required to determine what these strategies should be. Lastly, universal HIV screening of women with either PID or cervical cancer seems prudent.

Entities:  

Mesh:

Year:  1994        PMID: 8088616     DOI: 10.1006/gyno.1994.1226

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature.

Authors:  Gabriella Ferrandina; Vanda Salutari; Antonia Testa; Gian Franco Zannoni; Marco Petrillo; Giovanni Scambia
Journal:  BMC Cancer       Date:  2006-06-27       Impact factor: 4.430

2.  Metastatic carcinoma of cervix mimicking psoas abscess on imaging: a case report.

Authors:  Naveen Kalra; Senthilkumar Aiyappan; Raje Nijhawan; S C Sharma; Niranjan Khandelwal
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

3.  Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria.

Authors:  Solomon Odafe; Kwasi Torpey; Hadiza Khamofu; Edward Oladele; Oluwasanmi Adedokun; Otto Chabikuli; Halima Mukaddas; Yelwa Usman; Bolatito Aiyenigba; Macpaul Okoye
Journal:  Niger Med J       Date:  2013-05

Review 4.  MDCT of abdominopelvic oncologic emergencies.

Authors:  Sree Harsha Tirumani; Vijayanadh Ojili; Gowthaman Gunabushanam; Kedar N Chintapalli; John G Ryan; Caroline Reinhold
Journal:  Cancer Imaging       Date:  2013-07-22       Impact factor: 3.909

5.  A rare case of extensive skeletal muscle metastases in adenocarcinoma cervix identified by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography scan.

Authors:  Madan Gopal Vishnoi; Anurag Jain; Arun Ravi John; Dharmesh Paliwal
Journal:  Indian J Nucl Med       Date:  2016 Jul-Sep

Review 6.  Psoas abscess secondary to retroperitoneal distant metastases from squamous cell carcinoma of the cervix with thrombosis of the inferior vena cava and duodenal infiltration treated by Whipple procedure: A case report and review of the literature.

Authors:  Matthias Mehdorn; Tim-Ole Petersen; Michael Bartels; Boris Jansen-Winkeln; Woubet Tefera Kassahun
Journal:  BMC Surg       Date:  2016-08-11       Impact factor: 2.102

7.  Metastatic cervical carcinoma masquerading as iliopsoas abscess in an HIV negative woman-diagnosed on fine-needle aspiration cytology: A case report.

Authors:  Anuj Sharma; Aniruna Dey; Mitesh Gupta
Journal:  J Cytol       Date:  2015 Oct-Dec       Impact factor: 1.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.